In addition, the continuous activation of Akt independent of EGFR is also an important reason for the emergence of resistance to CTX therapy (1); therefore, Akt inhibition is a strategy to sensitize cancer cells to CTX (5). The gene discussed is EGFR; the disease is cancer.